Pharmacists in Attleboro, Massachusetts


30 Pharmacists found in Attleboro
female pharmacist

Dr. Madeleine Jenae Davies, PHARMD



28 Sturdy St, Attleboro, MA 02703
508-236-7892    

female pharmacist

Marie Claire Larouche, PHARMD


Pharmacist
78a Allenson Ave, Attleboro, MA 02703
508-838-7237    

female pharmacist

Dr. Megan Masse, RPH


Pharmacist
163 Pleasant St Ste 3, Attleboro, MA 02703
800-295-9564     844-818-7750



male pharmacist

Nitin Pai


Pharmacist
469 Pleasant St, Attleboro, MA 02703
508-226-5888    

female pharmacist

Purvi Shah, PHARMD


Pharmacist
196 Pleasant St, Attleboro, MA 02703
508-222-7779    

female pharmacist

Raquel Digirolamo, PHARMD


Pharmacist
191 N Main St, Attleboro, MA 02703
508-222-0880    

female pharmacist

Dr. Rebecca Das Dores Costa, PHARMD


Pharmacist
486 Pleasant St, Attleboro, MA 02703
508-222-6020    

female pharmacist

Rebecca Lynne Beaton, PHARMD


Pharmacist
191 N Main St, Attleboro, MA 02703
508-222-0880    

male pharmacist

Robert Alex Cargill Jr., RPH


Pharmacist
469 Pleasant St, Attleboro, MA 02703
508-226-2400    

male pharmacist

Ronald F Serak, RPH


Pharmacist
469 Pleasant St, Attleboro, MA 02703
508-226-5888    

male pharmacist

Sam Talala, PHARMD


Pharmacist - Pharmacotherapy
196 Pleasant St, Attleboro, MA 02703
508-222-7779    

female pharmacist

Sarah Flanagan, PHARMD


Pharmacist
196 Pleasant St, Attleboro, MA 02703
508-222-7779    

female pharmacist

Shruti Shah


Pharmacist
196 Pleasant St, Attleboro, MA 02703
508-222-7779    

male pharmacist

Stephen Akinbo


Pharmacist
196 Pleasant St, Attleboro, MA 02703
508-222-7779    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.